Ryusuke Shodo

5PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)ClinimetricsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 01, 2026
Feasibility and preliminary effects of combined exercise and nutritional intervention on muscle mass preservation during chemoradiotherapy for head and neck cancer: a prospective study.

|Jul 12, 2025
Oropharyngeal candidiasis during radiotherapy for head and neck cancer: an observational study on prevalence, pain, and risk factors.

Ryusuke Shodo, Yushi Ueki, Kouji Katsura

|Dec 09, 2023
Sarcopenia Index Predicts Short-Term Prognosis of Head and Neck Squamous Cell Carcinoma.

Ryusuke Shodo, Keisuke Yamazaki, Yushi Ueki

|Aug 11, 2020
Sarcopenia predicts a poor treatment outcome in patients with head and neck squamous cell carcinoma receiving concurrent chemoradiotherapy.

Ryusuke Shodo, Keisuke Yamazaki, Yushi Ueki

|Jul 17, 2020
Role of programmed death-ligand 1 in predicting the treatment outcome of salvage chemotherapy after nivolumab in recurrent/metastatic head and neck squamous cell carcinoma.

Yushi Ueki, Takeshi Takahashi, Hisayuki Ota

Pageof 1

Frequent Collaborators

1 joint publications

Yushi Ueki

1 joint publications

Takeshi Takahashi